Literature DB >> 21287787

Research on component law of Chinese patent medicine for anti-influenza and development of new recipes for anti-influenza by unsupervised data mining methods.

Shi-Huan Tang1, Jian-Xin Chen, Geng Li, Hong-Wei Wu, Chang Chen, Na Zhang, Na Gao, Hong-Jun Yang, Lu-Qi Huang.   

Abstract

OBJECTIVE: To analyze the component law of Chinese patent medicines for anti-influenza and develop new prescriptions for anti-influenza by unsupervised data mining methods.
METHODS: Chinese patent medicine recipes for anti-influenza were collected and recorded in the database, and then the correlation coefficient between herbs, core combinations of herbs and new prescriptions were analyzed by using modified mutual information, complex system entropy cluster and unsupervised hierarchical clustering, respectively.
RESULTS: Based on analysis of 126 Chinese patent medicine recipes, the frequency of each herb occurrence in these recipes, 54 frequently-used herb pairs, 34 core combinations were determined, and 4 new recipes for influenza were developed.
CONCLUSION: Unsupervised data mining methods are able to mine the component law quickly and develop new prescriptions.

Mesh:

Substances:

Year:  2010        PMID: 21287787     DOI: 10.1016/s0254-6272(10)60058-1

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  3 in total

Review 1.  A new strategy in drug design of Chinese medicine: theory, method and techniques.

Authors:  Hong-Jun Yang; Dan Shen; Hai-Yu Xu; Peng Lu
Journal:  Chin J Integr Med       Date:  2012-10-20       Impact factor: 1.978

2.  Baicalin Downregulates RLRs Signaling Pathway to Control Influenza A Virus Infection and Improve the Prognosis.

Authors:  Peng Pang; Ke Zheng; Sizhi Wu; Huachong Xu; Li Deng; Yucong Shi; Xiaoyin Chen
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-26       Impact factor: 2.629

3.  Reporting effectiveness of an extract of three traditional Cretan herbs on upper respiratory tract infection: results from a double-blind randomized controlled trial.

Authors:  G Duijker; A Bertsias; E K Symvoulakis; J Moschandreas; N Malliaraki; S P Derdas; G K Tsikalas; H E Katerinopoulos; S A Pirintsos; G Sourvinos; E Castanas; C Lionis
Journal:  J Ethnopharmacol       Date:  2015-01-30       Impact factor: 4.360

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.